Kenneth H. Mayer, Fenway Health

Fenway Health
Kenneth Mayer is Medical Research Director at Fenway Health, Professor of Medicine at Harvard Medical School and of Global Health and Population at the Harvard T.C. Chan School of Public Health. He an Infectious Disease Attending at Beth Israel Deaconess Medical Center in Boston

Presenter Of 4 Presentations

Non-Commercial Satellite

Welcome from the Co-chairs

Organizer
International AIDS Society; World Health Organization
Room
Satellite Channel 4
Non-Commercial Satellite

Summary of meeting by Co-chairs

Organizer
International AIDS Society; World Health Organization
Room
Satellite Channel 4

Moderator Of 1 Session

Non-Commercial Satellite
Organizer
International AIDS Society; World Health Organization
Room
Satellite Channel 4
Date
Sat, Jul 4, 2020
Time
08:00 AM - 09:00 AM
Session Description
The session aims to highlight the latest data, innovations and examples of good practice in relation to HIV and sexually transmitted infections (STIs), taking into consideration the current COVID-19 pandemic.

Presenter Of 1 Presentation

Symposia session

Conclusion

Room
Symposia and bridging sessions On-Demand Channel

Moderator Of 1 Session

Symposia session
Room
Symposia and bridging sessions On-Demand Channel
Session Description
This session will assess the complexities of HIV prevention trial design in the era of effective PrEP and discuss alternative designs and analytic techniques to help guide the design of future prevention trials. Given the proven efficacy of oral PrEP, the design of studies to determine the efficacy of new prevention technologies has become more complex. This session will be a state-of-the-art update of ongoing HIV prevention trials and new options coming soon into trials. It will explore theoretical and practical issues influencing trial design in an era when effective HIV prevention using oral PrEP is already widely available. This will include the use of different endpoints, new statistical analysis techniques, ethical considerations and practical issues of enrolling and randomizing patients in HIV prevention trials.

Presenter Of 1 Presentation

E-Posters

PEC0615 - Is PEP a gateway to PrEP? Experience from a high volume community health center

Session Name
E-posters Track C
Room
Poster Channel - Track C

Presenter Of 1 Presentation

Symposia session

Conclusion

Room
Symposia and bridging sessions On-Demand Channel

Moderator Of 1 Session

Symposia session
Room
Symposia and bridging sessions On-Demand Channel
Session Description
This session will assess the complexities of HIV prevention trial design in the era of effective PrEP and discuss alternative designs and analytic techniques to help guide the design of future prevention trials. Given the proven efficacy of oral PrEP, the design of studies to determine the efficacy of new prevention technologies has become more complex. This session will be a state-of-the-art update of ongoing HIV prevention trials and new options coming soon into trials. It will explore theoretical and practical issues influencing trial design in an era when effective HIV prevention using oral PrEP is already widely available. This will include the use of different endpoints, new statistical analysis techniques, ethical considerations and practical issues of enrolling and randomizing patients in HIV prevention trials.

Presenter Of 6 Presentations

Symposia session

Conclusion

Room
Symposia and bridging sessions On-Demand Channel
Non-Commercial Satellite

Welcome from the Co-chairs

Organizer
International AIDS Society; World Health Organization
Room
Satellite Channel 4
Non-Commercial Satellite

Summary of meeting by Co-chairs

Organizer
International AIDS Society; World Health Organization
Room
Satellite Channel 4
E-Posters

Is PEP a gateway to PrEP? Experience from a high volume community health center

Session Name
E-posters Track C
Room
Poster Channel - Track C

Moderator Of 2 Sessions

Non-Commercial Satellite
Organizer
International AIDS Society; World Health Organization
Room
Satellite Channel 4
Session Description
The session aims to highlight the latest data, innovations and examples of good practice in relation to HIV and sexually transmitted infections (STIs), taking into consideration the current COVID-19 pandemic.
Symposia session
Room
Symposia and bridging sessions On-Demand Channel
Session Description
This session will assess the complexities of HIV prevention trial design in the era of effective PrEP and discuss alternative designs and analytic techniques to help guide the design of future prevention trials. Given the proven efficacy of oral PrEP, the design of studies to determine the efficacy of new prevention technologies has become more complex. This session will be a state-of-the-art update of ongoing HIV prevention trials and new options coming soon into trials. It will explore theoretical and practical issues influencing trial design in an era when effective HIV prevention using oral PrEP is already widely available. This will include the use of different endpoints, new statistical analysis techniques, ethical considerations and practical issues of enrolling and randomizing patients in HIV prevention trials.